Atlas Trials

Determination of Epigenetic Markers of Acute Myeloblastic Leukemia in Elderly Patients

Clinical trial NCT07250217 · RECRUITING

Trial details

NCT number
NCT07250217
Sponsor
Groupe Hospitalier de la Region de Mulhouse et Sud Alsace
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Acute Myeloblastic Leukemia
Start date
2026-01-13
Primary completion
2027-12-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.